Additionally in GC and in hepatocellular carcinoma, Gal-3 activates GSK-3β, β-catenin, and the Insulin-like growth factor-binding protein 3; resulting in angiogenesis and EMT (80). This evidence concerns the gene LGALS3 and hepatocellular carcinoma.